SCHEMBL2963071

SCHEMBL2963071

COC1=CCc2cc(Br)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 2/20 0.38
SRD5A2 P31213 1/20 0.38
CYP3A4 P08684 1/20 0.36
METAP1 P53582 2/20 0.36
TDP2 O95551 1/20 0.35
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
GAA P10253 2/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
S100A4 P26447 1/20 0.32
ADRA2A P08913 1/20 0.32
PNMT P11086 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2972430 0.85 GAA (0.36) METAP1TDP2PARP10KDM4ETDP1
SCHEMBL2963487 0.75 METAP1 (0.39) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL6909323 0.72 CDC25A (0.38) CYP3A4KDM4ETDP1GAALMNA
SCHEMBL18769959 0.71 METAP1 (0.39) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL2968043 0.71 METAP1 (0.39) SRD5A1SRD5A2CYP3A4METAP1TDP2
SCHEMBL2975322 0.70 METAP1 (0.36) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL2965948 0.70 SRD5A1 (0.38) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL2959482 0.70 MPO (0.42) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL28457884 0.70 TDP2 (0.39) SRD5A1SRD5A2METAP1TDP2PARP10
SCHEMBL2967992 0.70 METAP1 (0.36) SRD5A1SRD5A2CYP3A4METAP1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 SRD5A1 3106/4885SRD5A2 2775/4885CYP3A4 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.